COMP <GO>
BDC vs TMO // FREE CASH FLOW YIELD
Belden Inc (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: BDC 7
— TMO 8
▲ FREE CASH FLOW YIELD LEADER: BDC
LAST: $105.70 (-1.66%) • MKT CAP: $4.20B
fcf-yield
5.21%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
fcf-yield
2.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BDC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.00% | 41.00% | -3.00 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.50% | 9.30% | +2.20 | BDC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.8x | 30.4x | -18.60 | BDC | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 5.21% | 2.40% | +2.81 | BDC | /fcf-yield <GO> |
| Operating Margin | 11.60% | 17.40% | -5.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 8.70% | 15.10% | -6.40 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 10.30% | 3.90% | +6.40 | BDC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.19% | 0.24% | -0.05 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.32 | 4.50 | -1.18 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | BDC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.70% | +0.60 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 59.1 | -13.12 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.94 | +0.17 | BDC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.5x | 36.3x | -19.80 | BDC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.20B | $262.22B | -$258.02B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BDC REV | TMO REV | BDC GROSS % | TMO GROSS % | BDC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $44.56B | 38.0% | 44.0% | $218.7M | $6.29B |
| FY 2024 | $2.46B | $42.88B | 37.5% | 44.0% | $223.0M | $7.27B |
| FY 2023 | $2.51B | $42.86B | 44.0% | 44.0% | $206.6M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDC // BETA 1.11
TMO // BETA 0.94